How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton.

Roope, Laurence S J; Buckell, John; Becker, Frauke; Candio, Paolo; Violato, Mara; Sindelar, Jody L; Barnett, Adrian; Duch, Raymond; Clarke, Philip M

Roope, Laurence S J; Buckell, John; Becker, Frauke; Candio, Paolo; Violato, Mara; Sindelar, Jody L; Barnett, Adrian; Duch, Raymond; Clarke, Philip M.

Roope LSJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Buckell J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Becker F; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Candio P; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Violato M; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Sindelar JL; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
Barnett A; School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia.
Duch R; Nuffield College, University of Oxford, Oxford, UK.
Clarke PM; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Philip.Clarke@ndph.ox.ac.uk.

Pharmacoecon Open ; 4(4): 557-561, 2020 Dec.

Article in English | MEDLINE | ID: covidwho-743797

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Topics: Vaccines Language: English Journal: Pharmacoecon Open Year: 2020 Document Type: Article Affiliation country: S41669-020-00228-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google